physician-scientist
(she/her/hers)

Hidradenitis Suppurativa (HS) is a prevalent and debilitating disease predominating in women and minorities. Despite its prevalence and morbidity, the biology of HS is poorly understood, thus limiting the development of effective therapies. Rigorous investigation of cutaneous dysbiosis (abnormal microbial colonization of skin) and immune dysregulation associated with HS is urgently needed to understand their roles in HS pathogenesis, and to guide the development of novel therapeutic approaches for this devastating disease.

Dr. Andrea Park is a facial plastic surgeon who cares for patients who have irregularities of the head or neck, whether these conditions are congenital, acquired or results of cancer treatment. Aiming to help her patients look and feel their best, she believes that trust, service and open communication are essential to a thriving patient-physician relationship.

My research uses computational methods to study the dynamic interplay between disease progression, treatment regimen, and drug and biomarker response across relevant scales (molecule, cell, tissue, organ & whole body) to determine causal links underlying variability in (safety and efficacy) clinical outcomes. By integrating multi-scale, and multi-level clinical data, we aim to determine the right dose, schedule, and treatment duration of various therapies, potentially bringing novel, precise and personalized treatment options to patients with unmet need more quickly.